JACQUELYN ISAACS: Open Payments
NPI 1487295572 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$965 in 53 payments from 13 companies in 2025. Trend: 2023 $885 · 2024 $990 · 2025 $965
Food & beverage: $965
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $273 |
| ABBVIE INC. | 12 | $201 |
| PFIZER INC. | 6 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $86 |
| Novo Nordisk Inc | 5 | $84 |
| Amgen Inc. | 4 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
Products named: AIRSUPRA, BREZTRI, VRAYLAR, Kerendia, NURTEC ODT, QULIPTA, UBRELVY, OTEZLA.
Industry payments across AR — which companies pay providers there.
